SEQLL, LLC
WOBURN, MA · Founded 2014 · CIK 0001605888 · Biotech · Acquired
Long-read DNA sequencing system using single-molecule real-time technology
seqll.com →- Grants
- $223K
- 1 award
- Sector median: 1
- Raised
- $2.5M
- 4 Form D · Feb 2021
- 68 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 1 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320142015201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Methods to enable direct RNA sequencing without amplification | $223,465 | |
| Private capital raised | Form D · SEC | $120,000 | |
| Private capital raised | Form D · SEC | $350,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1900 | ImmunoPrecise Antibodies Ltd. | — | $2.5M |
| 1901 | SYNSHARK LLC | — | $213K |
| 1902 | Blank! The Musical LLC | — | $550K |
| 1903 | SEQLL, LLC | — | $2.5M |
| 1904 | NANOMEDTRIX LLC | — | — |
| 1905 | Hemispherian AS | — | $108K |
| 1906 | MBF THERAPEUTICS, INC. | — | $2.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Charley CarterExecutive Officer
- Tisha JepsonExecutive Officer
- Dan JonesExecutive Officer
- Daniel JonesDirector · Executive Officer · Promoter
- John KennedyExecutive Officer
- Douglas MiscollDirector
- Elizabeth ReczekExecutive Officer
- William St. LaurentDirector · Executive Officer · Promoter
- Georges St. Laurent IIIDirector · Executive Officer · Promoter
Patents
- Combinatorial Single Molecule Analysis Of Chromatingranted
- Combinatorial Single Molecule Analysis Of Chromatinapplication
- Combinatorial Single Molecule Analysis Of Chromatinapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.